statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Concord Biotech rallies 8% as Kotak upgrades stock to 'add', sees 11% upside

After an impressive 220 bps EBITDA margin expansion in FY24, Concord is guiding for further improvement in FY25/26.

Bulk deals: Kotak Mahindra MF buys 3.86% in Prudent Corporate Advisory Services

Kotak Mahindra Mutual Fund bought around 16 lakh shares for an average price of Rs 1650 per share.

Stock Radar: LIC, Natco Pharma, Lumax Auto Tech, Adani Energy, Concord Biotech, Timken India in focus on Tuesday

Engineers India, Aditya Birla Fashion and Retail, Amara Raja Energy &amp; Mobility, Aster DM Healthcare, EIH, Exicom Tele-Systems, and IRCTC are among the 440 companies set to announce their March quarter earnings on Tuesday.

Ontario Inc to sell 3.4% in Concord Biotech, deal size worth Rs 468.40 crore: CNBC-TV18

The seller entity will have residual stake of two percent in the company after the transaction

Stock Radar: IndiGo, HCL Tech, Honasa Consumer, Fortis Healthcare, Zaggle Prepaid in focus on Friday

NTPC, Hindalco, Bosch, Ashok Leyland, Hindustan Copper, Glenmark Pharma, Aegis Logistics, Manappuram Finance, Suzlon Energy, Torrent Pharmaceuticals, and United Spirits will announce their March quarter earnings on May 24.

Concord Biotech Ltd. operates as a research and development based biotechnology company. It manufactures active pharmaceutical ingredients through the process of fermentation, semi-synthetic and synthetic processes. The firm''s products include APIs in the immunosuppressant, antibiotic, oncology, antifungal and hypolipemic segments and enzymes. The company was founded in 2000 and is headquartered in Ahmedabad, India.

Volume	29,036.00
52-Wk High	1,799.00
52-Wk Low	900.05

CONCORDBIO.NSE Concord Biotech Ltd.

About

Feed

News

Fundamentals